The Company

1

VLPbio is a pioneer biotechnology company focused on research and development of Chimeric Virus like Particles (VLPs) as vaccines for human health.                                                                                                                                                                                                                                     

VLPbio strategy aims to leverage its immunotherapy technology platform and know-how by targeting major pharmaceutical markets (cancer and cardiovascular, among others).

While maintaining R&D efforts to further stranghten its core technology, VLPbio will focus on the early clinical development (preclinical, Phase I, phase II) of its most advanced research projects in human health currently inintiating preclinical development.

Latest News

View All